Trans-anal total mesorectal excision in low rectal cancers : Preliminary oncological results of a comparative study
Copyright © 2020 Elsevier Masson SAS. All rights reserved..
OBJECTIVE: The management of lower rectal cancers is a therapeutic challenge both from the oncological and functional viewpoints. The aim of this study is to assess the oncological results and postoperative morbidity after transanal total mesorectal excision (TaTME) for low rectal cancer.
MATERIAL AND METHODS: In this monocentric retrospective study, we compared the quality of carcinologic resection and the morbidity-mortality between a group of 20 patients undergoing TaTME and 21 patients treated by abdomino-perineal resection (APR) between 2016 to 2019.
RESULTS: More patients had a positive circumferential resection margin (CRM) (≤1mm) in the APR group (47.6% vs. 5%; P<0.0036). The difference in the rates of grades I-II and III-IV complications (Clavien-Dindo classification) between the two groups was not statistically significant (50% vs. 57.1% and 5% vs. 9.5% in TaTME and APR, respectively; P=0.7579, P=1.00). The median follow-up was longer in the TaTME group (20 months vs. 11 months; P=0.58). The local recurrence rate did not differ between the two groups (5% vs. 4.8%; P=1.00) CONCLUSION: TaTME provides a reliable total mesorectal resection with an acceptable CRM. However, like any new technique, it requires experience and the learning curve is long.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:159 |
|---|---|
| Enthalten in: |
Journal of visceral surgery - 159(2022), 1 vom: 15. Feb., Seite 13-20 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jouppe, P-O [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 04.04.2022 Date Revised 05.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jviscsurg.2020.12.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM319230848 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM319230848 | ||
| 003 | DE-627 | ||
| 005 | 20231225171020.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jviscsurg.2020.12.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1064.xml |
| 035 | |a (DE-627)NLM319230848 | ||
| 035 | |a (NLM)33358754 | ||
| 035 | |a (PII)S1878-7886(20)30310-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jouppe, P-O |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Trans-anal total mesorectal excision in low rectal cancers |b Preliminary oncological results of a comparative study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.04.2022 | ||
| 500 | |a Date Revised 05.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a OBJECTIVE: The management of lower rectal cancers is a therapeutic challenge both from the oncological and functional viewpoints. The aim of this study is to assess the oncological results and postoperative morbidity after transanal total mesorectal excision (TaTME) for low rectal cancer | ||
| 520 | |a MATERIAL AND METHODS: In this monocentric retrospective study, we compared the quality of carcinologic resection and the morbidity-mortality between a group of 20 patients undergoing TaTME and 21 patients treated by abdomino-perineal resection (APR) between 2016 to 2019 | ||
| 520 | |a RESULTS: More patients had a positive circumferential resection margin (CRM) (≤1mm) in the APR group (47.6% vs. 5%; P<0.0036). The difference in the rates of grades I-II and III-IV complications (Clavien-Dindo classification) between the two groups was not statistically significant (50% vs. 57.1% and 5% vs. 9.5% in TaTME and APR, respectively; P=0.7579, P=1.00). The median follow-up was longer in the TaTME group (20 months vs. 11 months; P=0.58). The local recurrence rate did not differ between the two groups (5% vs. 4.8%; P=1.00) CONCLUSION: TaTME provides a reliable total mesorectal resection with an acceptable CRM. However, like any new technique, it requires experience and the learning curve is long | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a rectal cancer | |
| 650 | 4 | |a total mesorectal excision | |
| 650 | 4 | |a transanal total mesorectal excision | |
| 700 | 1 | |a Courtot, L |e verfasserin |4 aut | |
| 700 | 1 | |a Sindayigaya, R |e verfasserin |4 aut | |
| 700 | 1 | |a Moussata, D |e verfasserin |4 aut | |
| 700 | 1 | |a Barbieux, J-P |e verfasserin |4 aut | |
| 700 | 1 | |a Ouaissi, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of visceral surgery |d 2010 |g 159(2022), 1 vom: 15. Feb., Seite 13-20 |w (DE-627)NLM199191336 |x 1878-7886 |7 nnns |
| 773 | 1 | 8 | |g volume:159 |g year:2022 |g number:1 |g day:15 |g month:02 |g pages:13-20 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jviscsurg.2020.12.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 159 |j 2022 |e 1 |b 15 |c 02 |h 13-20 | ||